Roivant Sciences and Daiichi Sankyo Enter into Broad Pipeline ...
NEW YORK and BASEL, Switzerland, Dec. 19, 2018 /PRNewswireAsiaNet/ -- Roivant Sciences today announced that it has entered into a collaboration with Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) to facilitate the out-licensing of investigational medicines. Under the terms of the agreement, Roivant will...
Read more https://view-release/?pr-id=76835